Grant Esposito is a trial lawyer with particular expertise in complex commercial litigation involving life sciences, securities, and transactional disputes.
Grant works with clients to identify pragmatic and cost-effective solutions to their challenging legal problems, crafting case strategies aligned with their business objectives and needs. Grant sees the big picture and focuses on the key issues at stake, enabling him to position clients for successful outcomes whether during motion practice, a settlement, or at trial. A client noted that Grant “understands from the beginning your strengths and weaknesses and is not afraid to tell you.”
His legal acumen has been recognized by clients and leading publications in the field. He was named an American Lawyer Litigator of the Week, an IP MVP by Law360, and a Trailblazer in Intellectual Property Law by the National Law Journal. Grant has also been recognized in Chambers USA (New York–General Commercial Litigation), Legal 500 US (Litigation–Product Liability, pharmaceuticals and medical devices), and Best Lawyers in America (New York–Product Liability Litigation).
More About Grant
Grant counsels public companies on litigation risk, government investigations, and disclosure issues. In addition, Grant serves as a member of the firm’s Executive and Compensation Committees, and is a former chair of Morrison & Foerster’s Litigation Department.
Successfully defended Sprint and SoftBank against multiple State Attorneys’ General seeking to block the T-Mobile-Sprint merger as anti-competitive. After a two-week trial, the Court dismissed the States’ claims in their entirety and the merger closed.
Lead trial counsel in class action and individual cases alleging environmental contamination and toxic torts in excess of $1 billion. Advise client on related regulatory issues.
Represent interests of holders of more than $2 billion in bonds.
Defend client against claim of misappropriation of trade secrets.
Represented client in escrow dispute and related matters arising from $4.2 billion acquisition. Settled on favorable terms.
Designed statutory construction strategy that defined the “patent dance” contained in the Biologics Price Competition and Innovation Act, which was affirmed by the U.S. Supreme Court.
Secured dismissal of putative antitrust class action challenging patent settlement.
Secured dismissal of a False Claims Act lawsuit alleging off-label marketing and kickback scheme.
Trial counsel for Sandoz; prevailed on all patents.
Secured dismissals in New York, Boston, and Louisiana for auditor in alleged Ponzi scheme seeking hundreds of millions in damages.
Won a unanimous jury defense verdict in an actuarial malpractice case seeking in excess of $200 million.
Secured dismissal of securities fraud and negligence lawsuit against service provider.
Represented Canadian auditor in securities fraud proceedings; obtained favorable settlement.
Numerous confidential proceedings involving merger litigation, breach of contract, and payor-provider disputes.